SMS Lifesciences India Limited (SMSLIFE.BO)
INR 1350.85
(2.06%)
INR 1350.85
(2.06%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.9 Billion INR | -1.11% |
| 2022 | 3.94 Billion INR | 10.69% |
| 2021 | 3.56 Billion INR | 18.01% |
| 2020 | 3.02 Billion INR | 19.57% |
| 2019 | 2.52 Billion INR | -6.29% |
| 2018 | 2.69 Billion INR | 52.72% |
| 2017 | 1.76 Billion INR | 0.81% |
| 2016 | 1.75 Billion INR | 1.68% |
| 2015 | 1.72 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 3.9 Billion INR | -1.11% |
| 2023 Q4 | 3.9 Billion INR | 0.0% |
| 2023 Q2 | 3.33 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 3.75 Billion INR | 0.0% |
| 2022 FY | 3.94 Billion INR | 10.69% |
| 2022 Q4 | 3.94 Billion INR | 0.0% |
| 2021 Q4 | 3.56 Billion INR | 0.0% |
| 2021 Q2 | 3.42 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 3.56 Billion INR | 18.01% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 FY | 3.02 Billion INR | 19.57% |
| 2020 Q4 | 3.02 Billion INR | 0.0% |
| 2020 Q2 | 2.7 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 2.55 Billion INR | 0.0% |
| 2019 FY | 2.52 Billion INR | -6.29% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 2.52 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 2.33 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 2.69 Billion INR | 52.72% |
| 2018 Q4 | 2.69 Billion INR | 0.0% |
| 2017 FY | 1.76 Billion INR | 0.81% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 1.76 Billion INR | 0.0% |
| 2017 Q2 | 1.82 Billion INR | 0.0% |
| 2016 Q4 | 1.75 Billion INR | 0.0% |
| 2016 Q1 | - INR | 0.0% |
| 2016 FY | 1.75 Billion INR | 1.68% |
| 2015 FY | 1.72 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.78 Billion INR | -118.703% |
| Biocon Limited | 560.7 Billion INR | 99.304% |
| Blue Jet Healthcare Limited | 10.58 Billion INR | 63.118% |
| Concord Biotech Limited | 17 Billion INR | 77.038% |
| Dishman Carbogen Amcis Limited | 95.81 Billion INR | 95.924% |
| FERMENTA BIOTECH LIMITED | 5.47 Billion INR | 28.715% |
| GENOMIC VALLEY BIOTECH LIMITED | 43.33 Million INR | -8911.279% |
| Lyka Labs Limited | 1.56 Billion INR | -149.176% |
| Panacea Biotec Limited | 12.4 Billion INR | 68.524% |
| SAMSRITA LABS LIMITED | 155.51 Million INR | -2411.168% |
| Servoteach Industries Limited | 1591.00 INR | -245455148.272% |
| Supriya Lifescience Limited | 9.21 Billion INR | 57.609% |
| Syngene International Limited | 61.51 Billion INR | 93.652% |
| TAKE Solutions Limited | 881.05 Million INR | -343.243% |
| Titan Biotech Limited | 1.56 Billion INR | -149.406% |
| Transgene Biotek Limited | 324.4 Million INR | -1103.809% |
| Vanta Bioscience Limited | 853.96 Million INR | -357.301% |